Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBSep 9, 2024 · Pembrolizumab (brand name: Keytruda) is a cancer medicine given into your vein as a slow intravenous (IV) infusion that usually takes about 30 minutes. You will most likely receive this treatment in an outpatient clinic or hospital setting every 3 or 6 weeks.
Keytruda (pembrolizumab): Side effects, uses, cost, and more
WEBJun 27, 2024 · Generic or biosimilar version: Keytruda is a brand-name medication. It’s not available in a generic or biosimilar version. Biosimilars tend to cost less than brand-name medications.
Pembrolizumab - Wikipedia
WEBPembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.
Pembrolizumab (Intravenous Route) Description and Brand Names …
WEBJul 1, 2024 · Description and Brand Names. Drug information provided by: Merative, Micromedex® US Brand Name. Keytruda; Descriptions. Pembrolizumab injection is used to treat melanoma (a type of skin cancer) that has spread or cannot be removed by surgery.
KEYTRUDA® (pembrolizumab) - Official Site
WEBKEYTRUDA is a prescription medicine used to treat a kind of uterine cancer called advanced endometrial carcinoma. KEYTRUDA may be used with the chemotherapy medicines carboplatin and paclitaxel, and then KEYTRUDA may be used alone, in adults: when your cancer has spread (advanced), or; if your cancer has returned. KEYTRUDA may be used alone in ...
Pembrolizumab: Uses, Dosage, Side Effects & Warning - Drugs.com
WEBMar 26, 2024 · Generic name: pembrolizumab [ PEM-broe-LIZ-ue-mab ] Brand name: Keytruda. Dosage form: intravenous solution (25 mg/mL) Drug class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) Medically reviewed by Melisa Puckey, BPharm. Last updated on Mar 26, 2024.
Pembrolizumab: Uses, Interactions, Mechanism of Action
WEBHealth Canada Approved Drug Products: KEYTRUDA (pembrolizumab) solution for intravenous infusion EMA Summary of Product Characteristics: Keytruda (pembrolizumab) concentrate for solution for infusion (December 2023) [ Link ]
Pembrolizumab: Side Effects, Uses, Dosage, Interactions, Warnings …
WEBJun 21, 2024 · Pembrolizumab is available under the following different brand names: Keytruda. What Are Side Effects Associated with Using Pembrolizumab? Common side effects of Pembrolizumab include: fatigue. anemia. high blood sugar (hyperglycemia)
Keytruda (Pembrolizumab for Injection): Side Effects, Uses ... - RxList
WEBKEYTRUDA, in combination with carboplatin and paclitaxel, followed by KEYTRUDA as a single agent, is indicated for the treatment of adult patients with primary advanced or recurrent endometrial carcinoma.
Pembrolizumab (Keytruda): Uses & Side Effects - Cleveland Clinic
WEBPEMBROLIZUMAB (pem broe liz ue mab) is a monoclonal antibody. It is used to treat certain types of cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. COMMON BRAND NAME (S): Keytruda. Advertisement. Cleveland Clinic is a non-profit academic medical center.
- Some results have been removed